Seoul National University Bundang Hospital Establishes the first "International PSP Research and Treatment Center" in Korea

Contributed by: PR Newswire

Images

PR Newswire associated1

Tags

GemVax-&-KAEL-Korea

More Like This

PR Newswire associated0

GemVax Announces Topline Results from Phase 2a Progressive Supranuclear Palsy Clinical Trial at Neuro2024

Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens

Ferrer Advances Research into Progressive Supranuclear Palsy (PSP) with the Inclusion of the First Participant in a Phase II Clinical Trial

PR Newswire associated0

Center for Treatment of Paralysis and Reconstructive Nerve Surgery at Hackensack Meridian Jersey Shore University Medical Center Awarded Global Healthcare Accreditation

PR Newswire associated0

European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University

The new QPS Cell Therapy Unit in Springfield, Missouri is a Leukopak collection and blood product processing center designed to meet the exponentially growing demand for blood products to support cell and gene therapy work. (Photo: Business Wire)

QPS Launches New Leukopak and Cell Therapy Products Facility

PR Newswire associated0

Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

PR Newswire associated0

Orphalan becomes the first European company to enter in China's Wilson Disease market